INVO Fertility (IVF) Return on Capital Employed (2012 - 2025)
INVO Fertility (IVF) reported Return on Capital Employed of 193.08% for Q3 2025, down 39136.0% year-over-year from N/an in Q3 2024, and down 35.32% quarter-over-quarter from 142.68% in Q2 2025.
INVO Fertility (IVF) Return on Capital Employed (2012 - 2025) Analysis & Trends
INVO Fertility (IVF) has 14 years of Return on Capital Employed data on file, last reported at 193.08% in Q3 2025.
- Return on Capital Employed for Q3 2025 came in at 193.08%, down 39136.0% year-over-year; the trailing twelve-month figure through Sep 2025 was 193.08% (down 39136.0% YoY), and the FY2024 annual result was 13.13%, up 20482.0% from the prior year.
- Return on Capital Employed slipped to 193.08% in Q3 2025 per IVF's latest filing, from 142.68% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 198.28% in Q3 2024 and troughed at 1246.65% in Q1 2024.
- A 5-year average of 113.63% and a median of 65.2% in 2021 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2021 and 2024: Return on Capital Employed soared 3523633 bps in 2021, then sank 131163 bps in 2024.
- A 5-year view of Return on Capital Employed shows it stood at 17.7% in 2021, then slumped by 1816 bps to 339.1% in 2022, then soared by 80 bps to 69.26% in 2023, then jumped by 75 bps to 17.66% in 2024, then sank by 994 bps to 193.08% in 2025.
- Business Quant data shows IVF's Return on Capital Employed at 193.08% in Q3 2025, 142.68% in Q2 2025, and 85.92% in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 11.13% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 9.30% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 24.24% |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 11.57% |
| 10 | INVO Fertility | 5.10 Mn | 4.75 Mn | 629,345.00 | -193.08% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -193.08% |
| Jun 30, 2025 | -142.68% |
| Mar 31, 2025 | -85.92% |
| Dec 31, 2024 | -17.66% |
| Sep 30, 2024 | 198.28% |
| Jun 30, 2024 | 72.82% |
| Mar 31, 2024 | -1,246.65% |
| Dec 31, 2023 | -69.26% |
| Sep 30, 2023 | 7.09% |
| Jun 30, 2023 | 57.06% |
| Mar 31, 2023 | 64.98% |
| Dec 31, 2022 | -339.10% |
| Sep 30, 2022 | -100.30% |
| Jun 30, 2022 | -56.65% |
| Mar 31, 2022 | -31.22% |
| Dec 31, 2021 | -17.70% |
| Sep 30, 2021 | -114.41% |
| Jun 30, 2021 | -79.32% |
| Mar 31, 2021 | -65.20% |
| Dec 31, 2020 | -136.84% |